FGF23 and hyperphosphatemia: Hyperphosphatemia, vascular calcification, and elevated FGF23 concentrations are the components of CKD-MBD, which exacerbate cardiovascular disease, accounting for around 60% of deaths among patients with CKD on dialysis (Sprague et al., 2021).